Myofibrillar myopathy type 6 (MFM6) is a rare genetic muscle disorder that leads to severe muscle weakness and a drastically ...
Researchers developed human muscle models that demonstrate human-like functional and molecular responses to pharmaceutical ...
In a new research report, a team of scientists led by Johns Hopkins Medicine say people with severe obesity and a common type ...
In a new research report, a team of scientists led by Johns Hopkins Medicine say people with severe obesity and a common type ...
Researchers at the University Hospital Bonn have developed a humanized mouse model for myofibrillar myopathy type 6 (MFM6), revealing that impaired autophagy driven by a defective BAG3 protein leads ...
Engineers interested in creating artificial cells to deliver drugs to unhealthy parts of the body face a key challenge: for a ...
Magnesium, lion’s mane, creatine and collagen are marketed for perimenopause and menopause symptoms. But the evidence shows ...
Readout to Include One-Year Cohort 1 Results and Early Cohort 2 Data; Webcast Conference Call Planned to Review RIDGE-1 Data at ASGCT Additional ...
Learn how creatine may support healthy aging in women, including its effects on muscle, brain, bone, and mood—plus safety, ...
Myofibrillar myopathy type 6 (MFM6) is a rare genetic muscle disorder that leads to severe muscle weakness and a drastically shortened life expectancy due to a disruption in muscle protein regulation.
In a new study published in Genes & Development, research led by Dr Lila Allou at the MRC Laboratory of Medical Sciences (LMS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results